Basic research is currently investigating different approaches in this regard: for example, Lu et al (2014) developed a novel immunotherapeutic bispecific antibody for the recruitment of cytotoxic T‐cells to CLEC12A‐positive AML cells. The gene discussed is CLEC12A; the disease is acute myeloid leukemia.